Biotech Blog Archives: March 2008
·
28 March 2008
Upcoming talks
Posting has been light lately — I’ve been working hard on revising Building Biotechnology.
Off to the NIH next week to give my talk on biotechnology entrepreneurship.
Upcoming talk at Johns Hopkins Carey School of Business on a multifaceted dissection of the biotechnology industry.
continue reading... » 0 Comments
10 March 2008
New Biotechnology Books on Biotechnology Business Development and Biotechnology Education
Two new biotechnology books:
I’m proud to announce two new books featuring international best practices in biotechnology business development and biotechnology education. These new books respectively empower industry leaders operating in the dynamic biotechnology industry, and help address the global shortage of skilled biotechnology workers.
First Edition, March 2008
Perfect Bound, 342 pages, US$74.95
ISBN: 978-09734676-7-3
Homepage
Amazon
Best Practices in [...]
continue reading... » 0 Comments
4 March 2008
Drug Patent Expirations in March 2008
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in March 2008*Drugs may be covered by multiple patents
Tradename
Applicant
Generic Name
Patent Number
Patent Expiration
CARDIZEM CD
Biovail
diltiazem hydrochloride
5,002,776
MAR 26,2008
CARDURA XL
Pfizer
doxazosin mesylate
4,837,111
MAR 21,2008
CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER
Bayer Pharms
ciprofloxacin
4,957,922
MAR 18,2008
CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Bayer Pharms
ciprofloxacin
4,957,922
MAR 18,2008
ESCLIM
Women First Hlthcare
estradiol
4,842,864
MAR 25,2008
IFEX
Bristol Myers Squibb
ifosfamide
4,882,452
MAR 03,2008
IFEX/MESNEX KIT
Bristol Myers Squibb
ifosfamide; mesna
4,882,452
MAR 03,2008
NEXIUM
Astrazeneca
esomeprazole magnesium
4,738,974
MAR 01,2008
NEXIUM
Astrazeneca
esomeprazole magnesium
4,783,974
MAR 01,2008
RESCULA
R [...]
